Mr. Speaker, I think it is very important to clarify the situation that the hon. member is referring to, which has arisen in Ontario. I think there has been some confusion in relation to this particular situation involving PET scanning. The pharmaceuticals that are used in PET scanning require Health Canada authorization. In the case in question, Health Canada determined that the Mississauga operation is conducting a clinical trial that poses a risk to patients. Under Health Canada direction this clinic has suspended operations.
In the House of Commons on March 26th, 2003. See this statement in context.